arrow
G

George Papatheodoridis

General Hospital of Athens Laiko
H指数:88
被引数:3.4万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Progression to cirrhosis in chronic hepatitis D with mild-to-moderate fibrosis: Insights from a multicenter European cohort (vol 8, 101898, 2026)

慢性丁型肝炎伴轻度至中度纤维化进展为肝硬化的进程:来自多中心欧洲队列的见解(卷8,101898,2026)

2026-09-010
OA
Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma

肝病学:MASLD、病毒性肝炎、胆汁淤积性肝病、门静脉高压和肝细胞癌的新兴范式

2026-08-300
PRE
Postbleeding antithrombotic management in cardiovascular patients: insights from the Attica Bleeding Snapshot study

心血管患者出血后的抗血栓管理:来自Attica出血快照研究的见解

2026-08-010
PRE
Declining but persistent hepatocellular cancer risk beyond 10 years of entecavir or tenofovir in chronic hepatitis B: Results of the PAGE-B cohort

在慢性乙型肝炎中,恩替卡韦或替诺福韦治疗10年后肝癌风险下降但仍持续存在:PAGE-B队列研究结果

2026-07-060
OAAI
Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction–associated steatotic liver disease (MASLD) and metabolic dysfunction–associated steatohepatitis (MASH)

纠正:克服代谢功能障碍相关脂肪性肝病(MASLD)和代谢功能障碍相关脂肪性肝炎(MASH)患者在筛查、诊断和随访中的障碍

2026-06-240
OAAI
Evaluation of Sarcopenic Obesity in Patients with MASLD

评估MASLD患者的肌少性肥胖

2026-05-150
PRE
Ten-Year Follow-Up After 96 Weeks Treatment With Peginterferon Plus Tenofovir in Hepatitis D (HIDIT-II): Improved Clinical Outcome After Combination Therapy

Hepatitis D (HIDIT-II)研究:聚乙二醇干扰素联合替诺福韦治疗96周后的十年随访——联合疗法改善临床结局

2025-11-010
OAAI
Predictors of fibrosis, clinical events and mortality in MASLD: Data from the Global-MASLD study

Younossi, Z.M.; de Avila, L.; Petta, S.; Hagström, H.; Kim, S.U.; Nakajima, A.; Crespo, J.; Castera, L.; Alkhouri, N.; Zheng, M.H.; 等. MASLD的纤维化、临床事件及死亡率的预测因素:全球MASLD研究的数据. 肝病学 2025. [Google Scholar] [CrossRef]

2025-11-013
PRE
A multinational survey of physician knowledge about management of chronic hepatitis C

关于慢性丙型肝炎管理知识的医师跨国调查

2025-10-020
OAAI
Global performance of non-invasive tests in MASLD: Insights from the G-MASLD study

非侵入性试验在MASLD中的全球表现:G-MASLD研究的见解

2025-10-010
PRE